We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche Likely to Tap Barr, Mylan for Tamiflu Production, Analyst Says
Roche Likely to Tap Barr, Mylan for Tamiflu Production, Analyst Says
November 21, 2005
U.S.-based generic firms Mylan Laboratories and Barr Laboratories have a leg up in the race to win a sublicense for Roche’s highly sought-after antiviral Tamiflu, according to a Nov. 21 Banc of America Securities report